RUZURGI (amifampridine) recall in Canada: Product withdrawal
In plain language
This recall involves RUZURGI (amifampridine) 10 mg tablets sold in Canada. It's being recalled because it is no longer authorized for sale in Canada. Stop using the product and consult your healthcare professional for alternative treatment options.
What to do
- Stop using the product immediately.
- Consult your healthcare professional to discuss alternative treatment options.
- Access to RUZURGI may be available through the Special Access Program (SAP) on a case-by-case basis.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
RUZURGI (amifampridine) 10 mg tablets
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves RUZURGI (amifampridine) 10 mg tablets sold in Canada. It's being recalled because it is no longer authorized for sale in Canada. Stop using the product and consult your healthcare professional for alternative treatment options.
What should consumers do?
Stop using the product immediately. Consult your healthcare professional to discuss alternative treatment options. Access to RUZURGI may be available through the Special Access Program (SAP) on a case-by-case basis.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on January 20, 2023.
Is the RUZURGI brand affected by this recall?
Yes, RUZURGI products are affected by this recall. This recall involves RUZURGI (amifampridine) 10 mg tablets sold in Canada. It's being recalled because it is no longer authorized for sale in Canada. Stop using the product and consult your healthcare professional for alternative treatment options.